高渗氯化钠羟乙基淀粉40注射液抗失血性休克临床观察

The Clinical Study of Hypertonic Sodium Chloride Hydroxylethyl Starch 40 Injection on Anti-hemorrhagic Shock

目的 :考察高渗氯化钠羟乙基淀粉40注射液 (HSS40)抗休克作用的剂量范围 ,并对其临床疗效和安全性进行初步观察。方法 :以失血性休克患者为受试对象 ,观察静脉滴注HSS40后受试者血压变化和实验室检查指标的变化。结果 :应用HSS40在500ml范围内可迅速升高血压 ,有效率为100 % ;部分受试者血氯、血钠水平有一过性升高 ,给药后24小时恢复正常。结论 :HSS40在剂量为80ml～500ml范围内 ,安全有效 ,推荐临床用药剂量为300ml～500ml。

OBJECTIVE:To survey the dosage range,clinical effect and safety of hypertonic sodium chloride hydroxylethyl starch 40 injection(HSS40) on anti-hemorrhagic shock METHODS:The changes of blood pressure and laboratory examination indices were detected after HSS40 was infused into the patients who suffered from hemorrhagic shock RESULTS:HSS40 could rapidly raise the blood pressure in a dose below 500ml and the effective rate could reach 100% In part of patients,the levels of serum Cl- and Na+ increased temporarily and restored after 24 hours CONCLUSION:HSS40 was safe and effective in doses of 80ml～500ml The clinical doses of 300ml～500ml are recommended